Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Septin multimer autoantibodies in severe motor neuropathy mimicking lower motor neuron disease.

Brain : a journal of neurology·2026

Same author

Improved and customized dengue serodiagnostics through combined NS1/IgM testing and novel dual-cut-off IgG ELISA.

PLoS neglected tropical diseases·2026

Same author

Immune cell profiling reveals expanded stem cell-like memory T cells in anti-GAD65-associated neurological syndromes.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

ITPR1 autoantibody-associated autoimmunity as a cause of newly emerging cognitive decline mimicking Alzheimer's disease: Case report and brief review of the literature.

Journal of neuroimmunology·2025

Same author

Standardized indirect immunofluorescence-based detection of dermal-binding autoantibodies in pemphigoid diseases: a prospective international multicentre study.

The British journal of dermatology·2025

Same author

Coexistence of CN1A autoantibodies in GAD65 encephalitis exacerbates neurodegeneration : Novel autoantibodies in GAD65 encephalitis.

Journal of neuroinflammation·2025

Search research articles

Related Experiment Video

Updated: Apr 14, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Anti-neuronal autoantibodies: Current diagnostic challenges.

Christian Probst¹, Sandra Saschenbrecker¹, Winfried Stoecker¹

¹Institute for Experimental Immunology, Euroimmun, Luebeck, Germany.

Multiple Sclerosis and Related Disorders

|April 17, 2015

Summary

The discovery of new anti-neuronal antibodies has expanded neurological autoimmune diseases. Developing reliable tests for rare autoantibodies and understanding their syndrome associations are key for new therapies.

Keywords:

Anti-neuronal autoantibodies Biochip mosaic Indirect immunofluorescence test Inducible cell line Marker protein Paraneoplastic syndrome

More Related Videos

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

Related Experiment Videos

Last Updated: Apr 14, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

Area of Science:

Neurology
Immunology
Medical Diagnostics

Background:

The field of neurological autoimmune diseases has grown significantly over the last 15 years.
New anti-neuronal antibodies have been identified, broadening the spectrum of known diseases.
Challenges exist in developing standardized serological tests for autoantibodies, especially rare ones.

Purpose of the Study:

To address the technical challenges in detecting autoantibodies against complex cell surface structures.
To highlight the need for authentically presented target antigens in diagnostic assays.
To emphasize the benefits of multiplex analyses for understanding autoimmune processes and developing therapies.

Main Methods:

Review of current technical challenges in serological test systems.
Discussion of antigen presentation for complex cell surface targets.
Exploration of multiplex analysis for syndrome association research.

Main Results:

Discovery of new anti-neuronal antibodies has expanded the disease spectrum.
Technical hurdles impede the standardization of serological tests for rare autoantibodies.
Authentic antigen presentation is crucial for detecting antibodies against complex cell surface structures.

Conclusions:

Advancements in detecting autoantibodies are crucial for diagnosing and understanding neurological autoimmune diseases.
Multiplex analyses are vital for uncovering syndrome associations and advancing therapeutic strategies.
Overcoming technical challenges in serology is essential for future research and treatment development.